Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 3;10(3):476.
doi: 10.3390/healthcare10030476.

The Impact of Direct Oral Anticoagulant Prophylaxis for Thromboembolism in Thrombophilic Patients Undergoing Abdominoplastic Surgery

Pasquale Verolino  1 , Caterina Sagnelli  2 , Roberto Grella  1 , Giovanni Francesco Nicoletti  1 , Antonello Sica  3 , Mario Faenza  1
Affiliations

The Impact of Direct Oral Anticoagulant Prophylaxis for Thromboembolism in Thrombophilic Patients Undergoing Abdominoplastic Surgery

Pasquale Verolino et al. Healthcare (Basel). .

Abstract

Congenital or acquired thrombophilia is observed in 10-15% of the general population; therefore, careful screening is carried out in patients at higher risk of venous thrombo-embolism (VTE). High risk of VTE is a contraindication in patients undergoing abdominoplasty. We evaluated rivaroxaban, an oral Xa inhibitor, with enoxaparin, a subcutaneously low molecular weight heparin (LMWH), in 48 female patients with documented thrombophilia, undergoing thrombo-prophylaxis after abdominoplasty. Patients were stratified into two groups according to thrombo-prophylaxis procedure: enoxaparin Group (n = 28) and rivaroxaban Group (n = 20). Hematologic outcomes were evaluated including VTE and hematoma. No episodes of VTE occurred in both groups; two patients during their course of enoxaparin presented severe hematoma for drainage and hemostasis revision. This study suggests that abdominoplasty, in patients with thrombophilia, in combination with thrombo-prophylaxis can be performed safely. Rivaroxaban was as effective as LMWH for preventing VTE, with only a moderate risk of clinically relevant bleeding. More research is needed to determine the optimal timing and duration of prophylaxis in patients undergoing plastic surgery.

Keywords: abdominoplasty; hematoma; thromboembolism; thrombophilia; thromboprophylaxis; venous.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997;96:1102–1108. doi: 10.1161/01.CIR.96.4.1102. - DOI - PubMed
    1. Catto A.J., Carter A.M., Barrett J.H., Bamford J., Rice P.J., Grant P.J. Von Willebrand factor and factor VIII:C in acute cerebrovascular disease: Relationship to stroke subtype and mortality. Thromb. Haemost. 1997;77:1104–1108. - PubMed
    1. Cushman M., Tsai A.W., White R.H., Heckbert S.R., Wayne D., Enright R.P., Folsom A.R. Deep Vein Thrombosis and Pulmonary Embolism in Two Cohorts: The Longitudinal Investigation of Thromboembolism Etiology. Am. J. Med. 2004;117:19–25. doi: 10.1016/j.amjmed.2004.01.018. - DOI - PubMed
    1. Oger E. Incidence of venous thromboembolism: A community-based study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Thromb. Haemost. 2000;83:657–660. - PubMed
    1. Ferraro G., Grella R., D’Andrea F. Abdominoplasty: Thromboembolic risks for both sexes. Aesthetic Plast. Surg. 2004;28:412–416. doi: 10.1007/s00266-004-0021-9. - DOI - PubMed

LinkOut - more resources